Arcadia Biosciences, Inc. (RKDA) DCF Valuation

Arcadia Biosciences, Inc. (RKDA) DCF Valuation
  • Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
  • Design Profissional: Modelos Confiáveis ​​E Padrão Da Indústria
  • Pré-Construídos Para Uso Rápido E Eficiente
  • Não É Necessária Experiência; Fácil De Seguir

Arcadia Biosciences, Inc. (RKDA) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Explore the financial prospects of Arcadia Biosciences, Inc. (RKDA) with our user-friendly DCF Calculator! Enter your assumptions regarding growth, margins, and costs to calculate the intrinsic value of Arcadia Biosciences, Inc. (RKDA) and inform your investment strategy.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019
AY2
2020
AY3
2021
AY4
2022
AY5
2023
FY1
2024
FY2
2025
FY3
2026
FY4
2027
FY5
2028
Revenue 1.2 8.0 6.8 10.0 5.3 6.5 7.8 9.5 11.5 13.9
Revenue Growth, % 0 587.25 -15.61 46.84 -46.46 21.19 21.19 21.19 21.19 21.19
EBITDA -28.7 -5.4 -23.3 -13.6 -13.9 -6.0 -7.3 -8.9 -10.8 -13.0
EBITDA, % -2452.69 -67.72 -343.17 -137.07 -261.5 -93.54 -93.54 -93.54 -93.54 -93.54
Depreciation .2 .7 1.0 1.4 .3 .8 .9 1.1 1.4 1.7
Depreciation, % 16.6 8.24 15.41 13.69 5.38 11.86 11.86 11.86 11.86 11.86
EBIT -28.9 -6.1 -24.3 -15.0 -14.2 -6.1 -7.5 -9.0 -10.9 -13.3
EBIT, % -2469.29 -75.96 -358.58 -150.76 -266.89 -95.19 -95.19 -95.19 -95.19 -95.19
Total Cash 25.3 25.7 28.7 20.6 11.6 6.5 7.8 9.5 11.5 13.9
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .6 1.4 1.4 1.2 .5
Account Receivables, % 51.5 17.5 20.21 12.26 9.64
Inventories 1.8 3.8 4.4 2.6 2.0 3.6 4.3 5.2 6.3 7.7
Inventories, % 153.46 47.45 65.38 25.82 36.74 55.08 55.08 55.08 55.08 55.08
Accounts Payable .5 .7 1.4 .9 .8 1.2 1.5 1.8 2.2 2.7
Accounts Payable, % 42.09 9.04 20.81 9.09 15.03 19.21 19.21 19.21 19.21 19.21
Capital Expenditure -1.5 -2.3 -1.0 -.1 .0 -1.9 -2.3 -2.7 -3.3 -4.0
Capital Expenditure, % -126.35 -29.06 -14.85 -0.72318 -0.09380863 -28.95 -28.95 -28.95 -28.95 -28.95
Tax Rate, % -6.26 -6.26 -6.26 -6.26 -6.26 -6.26 -6.26 -6.26 -6.26 -6.26
EBITAT -28.9 -6.0 -24.3 -15.0 -15.1 -6.1 -7.4 -9.0 -10.9 -13.2
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -32.1 -10.2 -24.2 -12.2 -13.6 -9.3 -9.6 -11.6 -14.0 -17.0
WACC, % 9.76 9.75 9.76 9.76 9.76 9.76 9.76 9.76 9.76 9.76
PV UFCF
SUM PV UFCF -45.5
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -17
Terminal Value -224
Present Terminal Value -140
Enterprise Value -186
Net Debt -6
Equity Value -180
Diluted Shares Outstanding, MM 1
Equity Value Per Share -145.83

What You Will Get

  • Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real RKDA financials.
  • Real-World Data: Historical data and forward-looking estimates (highlighted in the yellow cells).
  • Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
  • Automatic Calculations: Instantly visualize how your inputs affect Arcadia Biosciences’ valuation.
  • Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
  • User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.

Key Features

  • Comprehensive Data: Arcadia Biosciences’ historical financial statements and pre-filled projections.
  • Customizable Inputs: Modify WACC, tax rates, revenue growth, and EBITDA margins as needed.
  • Real-Time Results: Observe Arcadia Biosciences’ intrinsic value update instantly.
  • Intuitive Visual Outputs: Dashboard graphs illustrate valuation outcomes and essential metrics.
  • Designed for Precision: A professional-grade tool for analysts, investors, and finance professionals.

How It Works

  • Step 1: Download the prebuilt Excel template featuring Arcadia Biosciences, Inc.’s (RKDA) data.
  • Step 2: Navigate through the pre-filled sheets to familiarize yourself with the essential metrics.
  • Step 3: Adjust forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
  • Step 4: Instantly see recalculated results, including Arcadia Biosciences, Inc.’s (RKDA) intrinsic value.
  • Step 5: Make well-informed investment decisions or create reports based on the results.

Why Choose This Calculator for Arcadia Biosciences, Inc. (RKDA)?

  • User-Friendly Interface: Perfect for both novice and experienced users.
  • Customizable Inputs: Adjust parameters to fit your specific analysis needs.
  • Real-Time Feedback: Watch as Arcadia’s valuation updates instantly with your changes.
  • Pre-Loaded Data: Comes equipped with Arcadia’s latest financial information for immediate insights.
  • Relied Upon by Experts: A go-to tool for investors and analysts aiming for informed decisions.

Who Should Use This Product?

  • Professional Investors: Develop comprehensive and accurate valuation models for analyzing portfolios related to Arcadia Biosciences, Inc. (RKDA).
  • Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
  • Consultants and Advisors: Offer clients precise valuation insights for Arcadia Biosciences, Inc. (RKDA) stock.
  • Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling.
  • Biotech Enthusiasts: Gain insights into how biotechnology firms like Arcadia Biosciences, Inc. (RKDA) are valued in the market.

What the Template Contains

  • Historical Data: Includes Arcadia Biosciences, Inc.’s past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate Arcadia Biosciences, Inc.’s intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of Arcadia Biosciences, Inc.’s financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.